AIC
KIN

AWM Investment Company’s Kindred Biosciences, Inc. KIN Stock Holding History

AWM Investment Company’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-131,090
Closed -$977K – 142
2014
Q4 		$977K Buy
+131,090
New +$1.11M 0.13% 112

Other funds holding KIN

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

AWM Investment Company's KIN Position: Q1 2015 in Review

AWM Investment Company sold out of Kindred Biosciences, Inc. (KIN) in Q1 2015, closing a stake of 131,090 shares — an estimated $977K sold.

AWM Investment Company first reported a position in KIN in Q4 2014 and held it in 1 quarter. The position peaked at $977K in Q4 2014. 60 funds tracked by Wall St. Rank hold KIN as of Q1 2015.

  • AWM Investment Company reported no remaining Kindred Biosciences, Inc. position as of Q1 2015 after selling out during the quarter.
  • AWM Investment Company sold 131,090 Kindred Biosciences, Inc. shares in Q1 2015, an estimated $977K.
  • AWM Investment Company first reported a position in Kindred Biosciences, Inc. in Q4 2014 and held it in 1 quarter.
  • AWM Investment Company's Kindred Biosciences, Inc. position peaked at $977K in Q4 2014.
  • 60 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2015.

Based on AWM Investment Company's 13F filing for Q1 2015, filed 8 May 2015.